ID   KITM_HUMAN              Reviewed;         265 AA.
AC   O00142; B4DGJ7; B4DZK7; B7ZAB1; E5KNQ5; E9PH08; O15238;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 4.
DT   12-APR-2017, entry version 162.
DE   RecName: Full=Thymidine kinase 2, mitochondrial;
DE            EC=2.7.1.21;
DE   AltName: Full=Mt-TK;
DE   Flags: Precursor;
GN   Name=TK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=9079672; DOI=10.1074/jbc.272.13.8454;
RA   Johansson M., Karlsson A.;
RT   "Cloning of the cDNA and chromosome localization of the gene for human
RT   thymidine kinase 2.";
RL   J. Biol. Chem. 272:8454-8458(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 34-61
RP   (ISOFORM 1), AND CHARACTERIZATION.
RC   TISSUE=Brain;
RX   PubMed=9989599; DOI=10.1016/S0014-5793(98)01711-6;
RA   Wang L., Munch-Petersen B., Herrstroem Sjoeberg A., Hellman U.,
RA   Bergman T., Joernvall H., Eriksson S.;
RT   "Human thymidine kinase 2: molecular cloning and characterisation of
RT   the enzyme activity with antiviral and cytostatic nucleoside
RT   substrates.";
RL   FEBS Lett. 443:170-174(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 6), AND SUBUNIT.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W.,
RA   Mindrinos M., Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
RN   [4]
RP   SEQUENCE REVISION.
RA   Wang L.;
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3; 4 AND 5).
RC   TISSUE=Brain, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   VARIANTS MTDPS2 ASN-121 AND ASN-212, FUNCTION, AND CHARACTERIZATION OF
RP   VARIANTS MTDPS2 ASN-121 AND ASN-212.
RX   PubMed=11687801; DOI=10.1038/ng751;
RA   Saada A., Shaag A., Mandel H., Nevo Y., Eriksson S., Elpeleg O.;
RT   "Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion
RT   myopathy.";
RL   Nat. Genet. 29:342-344(2001).
RN   [10]
RP   VARIANTS MTDPS2 MET-53; MET-108 AND ASN-121.
RX   PubMed=12391347; DOI=10.1212/01.WNL.0000028689.93049.9A;
RA   Mancuso M., Salviati L., Sacconi S., Otaegui D., Camano P., Marina A.,
RA   Bacman S., Moraes C.T., Carlo J.R., Garcia M., Garcia-Alvarez M.,
RA   Monzon L., Naini A.B., Hirano M., Bonilla E., Taratuto A.L.,
RA   DiMauro S., Vu T.H.;
RT   "Mitochondrial DNA depletion: mutations in thymidine kinase gene with
RT   myopathy and SMA.";
RL   Neurology 59:1197-1202(2002).
RN   [11]
RP   VARIANTS MTDPS2 MET-108 AND LYS-192, AND CHARACTERIZATION OF VARIANTS
RP   MTDPS2 MET-108 AND LYS-192.
RX   PubMed=15639197; DOI=10.1016/j.ymgme.2004.09.005;
RA   Wang L., Limongelli A., Vila M.R., Carrara F., Zeviani M.,
RA   Eriksson S.;
RT   "Molecular insight into mitochondrial DNA depletion syndrome in two
RT   patients with novel mutations in the deoxyguanosine kinase and
RT   thymidine kinase 2 genes.";
RL   Mol. Genet. Metab. 84:75-82(2005).
RN   [12]
RP   VARIANTS MTDPS2 MET-64 AND TRP-183.
RX   PubMed=15907288; DOI=10.1016/j.nmd.2005.03.010;
RA   Tulinius M., Moslemi A.-R., Darin N., Holme E., Oldfors A.;
RT   "Novel mutations in the thymidine kinase 2 gene (TK2) associated with
RT   fatal mitochondrial myopathy and mitochondrial DNA depletion.";
RL   Neuromuscul. Disord. 15:412-415(2005).
RN   [13]
RP   INVOLVEMENT IN PEOB3, VARIANTS PEOB3 TRP-183 AND ALA-188,
RP   CHARACTERIZATION OF VARIANTS PEOB3 TRP-183 AND ALA-188, AND SUBUNIT.
RX   PubMed=21937588; DOI=10.1093/hmg/ddr438;
RA   Tyynismaa H., Sun R., Ahola-Erkkilae S., Almusa H., Poeyhoenen R.,
RA   Korpela M., Honkaniemi J., Isohanni P., Paetau A., Wang L.,
RA   Suomalainen A.;
RT   "Thymidine kinase 2 mutations in autosomal recessive progressive
RT   external ophthalmoplegia with multiple mitochondrial DNA deletions.";
RL   Hum. Mol. Genet. 21:66-75(2012).
RN   [14]
RP   VARIANTS MTDPS2 VAL-117 AND VAL-139.
RX   PubMed=25446393; DOI=10.1016/j.mito.2014.10.007;
RA   Knierim E., Seelow D., Gill E., von Moers A., Schuelke M.;
RT   "Clinical application of whole exome sequencing reveals a novel
RT   compound heterozygous TK2-mutation in two brothers with rapidly
RT   progressive combined muscle-brain atrophy, axonal neuropathy, and
RT   status epilepticus.";
RL   Mitochondrion 20:1-6(2015).
CC   -!- FUNCTION: Phosphorylates thymidine, deoxycytidine, and
CC       deoxyuridine in the mitochondrial matrix. In non-replicating
CC       cells, where cytosolic dNTP synthesis is down-regulated, mtDNA
CC       synthesis depends solely on TK2 and DGUOK. Widely used as target
CC       of antiviral and chemotherapeutic agents.
CC       {ECO:0000269|PubMed:11687801}.
CC   -!- CATALYTIC ACTIVITY: ATP + thymidine = ADP + thymidine 5'-
CC       phosphate.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:20843780,
CC       ECO:0000269|PubMed:21937588}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=O00142-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00142-2; Sequence=VSP_003028;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O00142-3; Sequence=VSP_043503;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=O00142-4; Sequence=VSP_044459;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=O00142-5; Sequence=VSP_054606;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=O00142-6; Sequence=VSP_058694;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in liver, pancreas,
CC       muscle, and brain.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 2 (MTDPS2)
CC       [MIM:609560]: A disorder due to mitochondrial dysfunction
CC       characterized by childhood onset of muscle weakness associated
CC       with depletion of mtDNA in skeletal muscle. There is wide clinical
CC       variability; some patients have onset in infancy and show a
CC       rapidly progressive course with early death due to respiratory
CC       failure, whereas others have later onset of a slowly progressive
CC       myopathy. {ECO:0000269|PubMed:11687801,
CC       ECO:0000269|PubMed:12391347, ECO:0000269|PubMed:15639197,
CC       ECO:0000269|PubMed:15907288, ECO:0000269|PubMed:25446393}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial
CC       DNA deletions, autosomal recessive 3 (PEOB3) [MIM:617069]: A form
CC       of progressive external ophthalmoplegia, a mitochondrial myopathy
CC       characterized by progressive paralysis of the levator palpebrae,
CC       orbicularis oculi, and extraocular muscles. PEOB3 patients
CC       manifest adult-onset progressive external ophthalmoplegia and
CC       progressive proximal muscle weakness associated with muscle
CC       atrophy. {ECO:0000269|PubMed:21937588}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DCK/DGK family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U77088; AAC51167.1; -; mRNA.
DR   EMBL; Y10498; CAA71523.3; -; mRNA.
DR   EMBL; AK294627; BAG57808.1; -; mRNA.
DR   EMBL; AK302976; BAG64119.1; -; mRNA.
DR   EMBL; AK316226; BAH14597.1; -; mRNA.
DR   EMBL; AC010542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471092; EAW83013.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW83015.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW83017.1; -; Genomic_DNA.
DR   EMBL; HQ205385; ADP90853.1; -; Genomic_DNA.
DR   EMBL; HQ205382; ADP90850.1; -; Genomic_DNA.
DR   EMBL; HQ205383; ADP90851.1; -; Genomic_DNA.
DR   EMBL; HQ205384; ADP90852.1; -; Genomic_DNA.
DR   EMBL; HQ205381; ADP90849.1; -; Genomic_DNA.
DR   EMBL; HQ205380; ADP90848.1; -; Genomic_DNA.
DR   EMBL; HQ205379; ADP90847.1; -; Genomic_DNA.
DR   EMBL; HQ205378; ADP90846.1; -; Genomic_DNA.
DR   EMBL; HQ205377; ADP90845.1; -; Genomic_DNA.
DR   EMBL; HQ205376; ADP90844.1; -; Genomic_DNA.
DR   EMBL; HQ205375; ADP90843.1; -; Genomic_DNA.
DR   EMBL; HQ205374; ADP90842.1; -; Genomic_DNA.
DR   EMBL; HQ205373; ADP90841.1; -; Genomic_DNA.
DR   EMBL; HQ205372; ADP90840.1; -; Genomic_DNA.
DR   EMBL; HQ205371; ADP90839.1; -; Genomic_DNA.
DR   EMBL; HQ205370; ADP90838.1; -; Genomic_DNA.
DR   EMBL; HQ205362; ADP90830.1; -; Genomic_DNA.
DR   EMBL; HQ205363; ADP90831.1; -; Genomic_DNA.
DR   EMBL; HQ205364; ADP90832.1; -; Genomic_DNA.
DR   EMBL; HQ205365; ADP90833.1; -; Genomic_DNA.
DR   EMBL; HQ205366; ADP90834.1; -; Genomic_DNA.
DR   EMBL; HQ205367; ADP90835.1; -; Genomic_DNA.
DR   EMBL; HQ205368; ADP90836.1; -; Genomic_DNA.
DR   EMBL; HQ205369; ADP90837.1; -; Genomic_DNA.
DR   EMBL; HQ205346; ADP90814.1; -; Genomic_DNA.
DR   EMBL; HQ205347; ADP90815.1; -; Genomic_DNA.
DR   EMBL; HQ205348; ADP90816.1; -; Genomic_DNA.
DR   EMBL; HQ205349; ADP90817.1; -; Genomic_DNA.
DR   EMBL; HQ205350; ADP90818.1; -; Genomic_DNA.
DR   EMBL; HQ205351; ADP90819.1; -; Genomic_DNA.
DR   EMBL; HQ205352; ADP90820.1; -; Genomic_DNA.
DR   EMBL; HQ205353; ADP90821.1; -; Genomic_DNA.
DR   EMBL; HQ205354; ADP90822.1; -; Genomic_DNA.
DR   EMBL; HQ205355; ADP90823.1; -; Genomic_DNA.
DR   EMBL; HQ205356; ADP90824.1; -; Genomic_DNA.
DR   EMBL; HQ205357; ADP90825.1; -; Genomic_DNA.
DR   EMBL; HQ205358; ADP90826.1; -; Genomic_DNA.
DR   EMBL; HQ205359; ADP90827.1; -; Genomic_DNA.
DR   EMBL; HQ205360; ADP90828.1; -; Genomic_DNA.
DR   EMBL; HQ205361; ADP90829.1; -; Genomic_DNA.
DR   CCDS; CCDS10805.2; -. [O00142-1]
DR   CCDS; CCDS54016.1; -. [O00142-3]
DR   CCDS; CCDS54017.1; -. [O00142-4]
DR   CCDS; CCDS54018.1; -. [O00142-2]
DR   CCDS; CCDS61955.1; -. [O00142-5]
DR   RefSeq; NP_001166114.1; NM_001172643.1. [O00142-2]
DR   RefSeq; NP_001166115.1; NM_001172644.1. [O00142-3]
DR   RefSeq; NP_001258864.1; NM_001271935.1.
DR   RefSeq; NP_001258979.1; NM_001272050.1. [O00142-5]
DR   RefSeq; NP_004605.4; NM_004614.4. [O00142-1]
DR   UniGene; Hs.512619; -.
DR   ProteinModelPortal; O00142; -.
DR   SMR; O00142; -.
DR   BioGrid; 112939; 8.
DR   STRING; 9606.ENSP00000414334; -.
DR   BindingDB; O00142; -.
DR   ChEMBL; CHEMBL4580; -.
DR   DrugBank; DB02594; 2'-Deoxycytidine.
DR   DrugBank; DB04485; Deoxythymidine.
DR   DrugBank; DB02452; Thymidine-5'-Triphosphate.
DR   iPTMnet; O00142; -.
DR   PhosphoSitePlus; O00142; -.
DR   BioMuta; TK2; -.
DR   MaxQB; O00142; -.
DR   PaxDb; O00142; -.
DR   PeptideAtlas; O00142; -.
DR   PRIDE; O00142; -.
DR   Ensembl; ENST00000299697; ENSP00000299697; ENSG00000166548. [O00142-1]
DR   Ensembl; ENST00000451102; ENSP00000414334; ENSG00000166548. [O00142-6]
DR   Ensembl; ENST00000525974; ENSP00000434594; ENSG00000166548. [O00142-5]
DR   Ensembl; ENST00000527284; ENSP00000435312; ENSG00000166548. [O00142-2]
DR   Ensembl; ENST00000527800; ENSP00000433770; ENSG00000166548. [O00142-5]
DR   Ensembl; ENST00000544898; ENSP00000440898; ENSG00000166548. [O00142-1]
DR   Ensembl; ENST00000545043; ENSP00000438143; ENSG00000166548. [O00142-3]
DR   Ensembl; ENST00000563369; ENSP00000463560; ENSG00000166548. [O00142-5]
DR   Ensembl; ENST00000620035; ENSP00000483833; ENSG00000166548. [O00142-4]
DR   GeneID; 7084; -.
DR   KEGG; hsa:7084; -.
DR   UCSC; uc002eor.4; human. [O00142-1]
DR   CTD; 7084; -.
DR   DisGeNET; 7084; -.
DR   GeneCards; TK2; -.
DR   GeneReviews; TK2; -.
DR   H-InvDB; HIX0021286; -.
DR   HGNC; HGNC:11831; TK2.
DR   HPA; HPA041162; -.
DR   MalaCards; TK2; -.
DR   MIM; 188250; gene.
DR   MIM; 609560; phenotype.
DR   MIM; 617069; phenotype.
DR   neXtProt; NX_O00142; -.
DR   OpenTargets; ENSG00000166548; -.
DR   Orphanet; 254886; Autosomal recessive progressive external ophthalmoplegia.
DR   Orphanet; 254875; Mitochondrial DNA depletion syndrome, myopathic form.
DR   PharmGKB; PA36535; -.
DR   eggNOG; KOG4235; Eukaryota.
DR   eggNOG; COG1428; LUCA.
DR   GeneTree; ENSGT00510000046588; -.
DR   HOGENOM; HOG000006872; -.
DR   HOVERGEN; HBG006216; -.
DR   InParanoid; O00142; -.
DR   KO; K00857; -.
DR   OrthoDB; EOG091G0PXX; -.
DR   PhylomeDB; O00142; -.
DR   TreeFam; TF324413; -.
DR   BioCyc; MetaCyc:HS09420-MONOMER; -.
DR   BRENDA; 2.7.1.21; 2681.
DR   Reactome; R-HSA-113510; E2F mediated regulation of DNA replication.
DR   Reactome; R-HSA-69205; G1/S-Specific Transcription.
DR   Reactome; R-HSA-73614; Pyrimidine salvage reactions.
DR   SABIO-RK; O00142; -.
DR   GenomeRNAi; 7084; -.
DR   PRO; PR:O00142; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000166548; -.
DR   CleanEx; HS_TK2; -.
DR   ExpressionAtlas; O00142; baseline and differential.
DR   Genevisible; O00142; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004137; F:deoxycytidine kinase activity; IEA:Ensembl.
DR   GO; GO:0019206; F:nucleoside kinase activity; TAS:Reactome.
DR   GO; GO:0004797; F:thymidine kinase activity; TAS:ProtInc.
DR   GO; GO:0046092; P:deoxycytidine metabolic process; IEA:Ensembl.
DR   GO; GO:0071897; P:DNA biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome.
DR   GO; GO:0046104; P:thymidine metabolic process; IEA:Ensembl.
DR   InterPro; IPR002624; DCK/DGK.
DR   InterPro; IPR031314; DNK_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF01712; dNK; 1.
DR   PIRSF; PIRSF000705; DNK; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Disease mutation; DNA synthesis; Kinase;
KW   Mitochondrion; Nucleotide-binding;
KW   Progressive external ophthalmoplegia; Reference proteome; Transferase;
KW   Transit peptide.
FT   TRANSIT       1     33       Mitochondrion.
FT   CHAIN        34    265       Thymidine kinase 2, mitochondrial.
FT                                /FTId=PRO_0000016842.
FT   NP_BIND      57     65       ATP. {ECO:0000250}.
FT   ACT_SITE    133    133       Proton acceptor. {ECO:0000255}.
FT   BINDING      81     81       Substrate. {ECO:0000250}.
FT   BINDING      99     99       Substrate. {ECO:0000250}.
FT   BINDING     110    110       Substrate. {ECO:0000250}.
FT   BINDING     134    134       Substrate. {ECO:0000250}.
FT   BINDING     201    201       Substrate. {ECO:0000250}.
FT   VAR_SEQ       1     97       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054606.
FT   VAR_SEQ       1     41       MLLWPLRGWAARALRCFGPGSRGSPASGPGPRRVQRRAWPP
FT                                -> MGAFCQRPSS (in isoform 2).
FT                                {ECO:0000303|PubMed:9079672}.
FT                                /FTId=VSP_003028.
FT   VAR_SEQ       1      1       M -> MRPGLFKGQAPGSRRRPTAGLAVVRADSHKKEPRAS
FT                                GSARPAM (in isoform 6).
FT                                {ECO:0000303|PubMed:20843780}.
FT                                /FTId=VSP_058694.
FT   VAR_SEQ      53     77       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043503.
FT   VAR_SEQ      78     95       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044459.
FT   VARIANT      53     53       I -> M (in MTDPS2; dbSNP:rs137854432).
FT                                {ECO:0000269|PubMed:12391347}.
FT                                /FTId=VAR_019419.
FT   VARIANT      64     64       T -> M (in MTDPS2; dbSNP:rs281865487).
FT                                {ECO:0000269|PubMed:15907288}.
FT                                /FTId=VAR_023790.
FT   VARIANT     108    108       T -> M (in MTDPS2; reduction of activity;
FT                                dbSNP:rs137854431).
FT                                {ECO:0000269|PubMed:12391347,
FT                                ECO:0000269|PubMed:15639197}.
FT                                /FTId=VAR_019420.
FT   VARIANT     117    117       M -> V (in MTDPS2; severe form of
FT                                combined brain and muscular atrophy;
FT                                depletion of mtDNA in skeletal muscle;
FT                                normal residual mtDNA in blood and
FT                                fibroblasts).
FT                                {ECO:0000269|PubMed:25446393}.
FT                                /FTId=VAR_072789.
FT   VARIANT     121    121       H -> N (in MTDPS2; reduction of activity
FT                                in muscles; dbSNP:rs137854429).
FT                                {ECO:0000269|PubMed:11687801,
FT                                ECO:0000269|PubMed:12391347}.
FT                                /FTId=VAR_019421.
FT   VARIANT     139    139       A -> V (in MTDPS2; severe form of
FT                                combined brain and muscular atrophy;
FT                                depletion of mtDNA in skeletal muscle;
FT                                normal residual mtDNA in blood and
FT                                fibroblasts; dbSNP:rs281865494).
FT                                {ECO:0000269|PubMed:25446393}.
FT                                /FTId=VAR_072790.
FT   VARIANT     183    183       R -> W (in MTDPS2 and PEOB3; reduction of
FT                                activity; reduced affinity for ATP;
FT                                dbSNP:rs137886900).
FT                                {ECO:0000269|PubMed:15907288,
FT                                ECO:0000269|PubMed:21937588}.
FT                                /FTId=VAR_023791.
FT   VARIANT     188    188       T -> A (in PEOB3; reduction of activity;
FT                                reduced affinity for ATP;
FT                                dbSNP:rs281865495).
FT                                {ECO:0000269|PubMed:21937588}.
FT                                /FTId=VAR_076984.
FT   VARIANT     192    192       R -> K (in MTDPS2; reduction of activity;
FT                                dbSNP:rs281865496).
FT                                {ECO:0000269|PubMed:15639197}.
FT                                /FTId=VAR_023792.
FT   VARIANT     212    212       I -> N (in MTDPS2; reduction of activity
FT                                in muscles; dbSNP:rs137854430).
FT                                {ECO:0000269|PubMed:11687801}.
FT                                /FTId=VAR_019422.
FT   CONFLICT     37     37       R -> Y (in Ref. 2; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     49     49       K -> E (in Ref. 5; BAG57808).
FT                                {ECO:0000305}.
FT   CONFLICT     61     61       S -> G (in Ref. 1; AAC51167).
FT                                {ECO:0000305}.
FT   CONFLICT    206    206       L -> P (in Ref. 5; BAG57808).
FT                                {ECO:0000305}.
FT   CONFLICT    238    238       D -> DH (in Ref. 2; CAA71523).
FT                                {ECO:0000305}.
FT   CONFLICT    241    241       Missing (in Ref. 1; AAC51167).
FT                                {ECO:0000305}.
FT   CONFLICT    251    251       N -> S (in Ref. 5; BAG57808).
FT                                {ECO:0000305}.
SQ   SEQUENCE   265 AA;  31005 MW;  1E9CB62D0321A992 CRC64;
     MLLWPLRGWA ARALRCFGPG SRGSPASGPG PRRVQRRAWP PDKEQEKEKK SVICVEGNIA
     SGKTTCLEFF SNATDVEVLT EPVSKWRNVR GHNPLGLMYH DASRWGLTLQ TYVQLTMLDR
     HTRPQVSSVR LMERSIHSAR YIFVENLYRS GKMPEVDYVV LSEWFDWILR NMDVSVDLIV
     YLRTNPETCY QRLKKRCREE EKVIPLEYLE AIHHLHEEWL IKGSLFPMAA PVLVIEADHH
     MERMLELFEQ NRDRILTPEN RKHCP
//
